Atlas Trials

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Clinical trial NCT00857233 · TERMINATED

Trial details

NCT number
NCT00857233
Sponsor
H. Lundbeck A/S
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2004-06-01
Primary completion
2010-07-01
Enrollment
297

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.